Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions

Hamed, Sonja ; Behnes, Michael ; Pauly, Dominic ; Lepiorz, Dominic ; Barre, Max ; Becher, Tobias ; Lang, Siegfried ; Akin, Ibrahim ; Borggrefe, Martin ; Bertsch, Thomas ; Hoffmann, Ursula

In: BMC Infectious Diseases, 17 (2017), Nr. 554. pp. 1-10. ISSN 1471-2334

[img]
Preview
PDF, English
Download (1MB) | Lizenz: Creative Commons LizenzvertragDiagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions by Hamed, Sonja ; Behnes, Michael ; Pauly, Dominic ; Lepiorz, Dominic ; Barre, Max ; Becher, Tobias ; Lang, Siegfried ; Akin, Ibrahim ; Borggrefe, Martin ; Bertsch, Thomas ; Hoffmann, Ursula underlies the terms of Creative Commons Attribution 3.0 Germany

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.

Abstract

Background: Pentraxin-3 (PTX-3) is an acute-phase protein involved in inflammatory and infectious processes. This study assesses its diagnostic and prognostic value in patients with sepsis or septic shock in a medical intensive care unit (ICU). Methods: The study includes 213 ICU patients with clinical criteria of sepsis and septic shock. 77 donors served as controls. Plasma levels of PTX-3, procalcitonin (PCT) and interleukin-6 were measured on day 1, 3 and 8. Results: PTX-3 correlated with higher lactate levels as well as with APACHE II and SOFA scores (p = 0.0001). PTX-3 levels of patients with sepsis or septic shock were consistently significantly higher than in the control group (p ≤ 0.001). Plasma levels were able to discriminate sepsis and septic shock significantly on day 1, 3 and 8 (range of AUC 0.73–0.92, p = 0.0001). Uniform cut-off levels were defined at ≥5 ng/ml for at least sepsis, ≥9 ng/ml for septic shock (p = 0.0001). Conclusion: PTX-3 reveals diagnostic value for sepsis and septic shock during the first week of intensive care treatment, comparable to interleukin-6 according to latest Sepsis-3 definitions. Trial registration: NCT01535534. Registered 14.02.2012

Item Type: Article
Journal or Publication Title: BMC Infectious Diseases
Volume: 17
Number: 554
Publisher: BioMed Central; Springer
Place of Publication: London; Berlin; Heidelberg
Date Deposited: 15 Aug 2017 12:40
Date: 2017
ISSN: 1471-2334
Page Range: pp. 1-10
Faculties / Institutes: Medizinische Fakultät Mannheim > Institut für Klinische Chemie
Medizinische Fakultät Mannheim > Medizinische Klinik - Lehrstuhl für Innere Medizin I
Subjects: 610 Medical sciences Medicine
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative